Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Laura Hernández Vanegas"'
Autor:
Miguel García‐Grimshaw, Javier Andrés Galnares‐Olalde, Omar Yaxmehen Bello‐Chavolla, Anaclara Michel‐Chávez, Arturo Cadena‐Fernández, María Eugenia Briseño‐Godínez, Neftali Eduardo Antonio‐Villa, Isaac Núñez, Alonso Gutiérrez‐Romero, Laura Hernández‐Vanegas, María del Mar Saniger‐Alba, Roger Carrillo‐Mezo, Santa Elizabeth Ceballos‐Liceaga, Guillermo Carbajal‐Sandoval, Fernando Daniel Flores‐Silva, José Luis Díaz‐Ortega, Ricardo Cortes‐Alcalá, José Rogelio Pérez‐Padilla, Hugo López‐Gatell, Erwin Chiquete, Gustavo Reyes‐Terán, Antonio Arauz, Sergio Iván Valdés‐Ferrer
Publikováno v:
European journal of neurologyREFERENCES. 29(11)
Information on Guillain-Barré syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 remains scarce. We aimed to report GBS incidence as an AEFI among adult (≥18 years) recipients of 81,842,426 doses of seven anti-SARS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9162a349325e2f673cfb161cdddfb243
https://pubmed.ncbi.nlm.nih.gov/35841212
https://pubmed.ncbi.nlm.nih.gov/35841212
Autor:
Miguel García-Grimshaw, Javier Andrés Galnares-Olalde, Omar Yaxmehen Bello-Chavolla, Anaclara Michel-Chávez, Arturo Cadena-Fernández, María Eugenia Briseño-Godínez, Neftali Eduardo Antonio-Villa, Isaac Nuñez, Alonso Gutiérrez-Romero, Laura Hernández-Vanegas, María del Mar Saniger-Alba, Roger Carrillo-Mezo, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, Fernando Daniel Flores-Silva, José Luis Díaz-Ortega, Hugo López-Gatell, Ricardo Cortes-Alcalá, José Rogelio Pérez-Padilla, Erwin Chiquete, Gustavo Reyes-Terán, Antonio Arauz, Sergio Iván Valdés-Ferrer
SummaryBackgroundGuillain-Barré syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 has been linked to a few (ChAdOx1 nCov-19 and Ad26.COV2-S), but not all vaccines, including mRNA-based ones. Epidemiological informat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81f20890cca6df6bd88be66c1c3ae1f9
https://doi.org/10.1101/2022.04.11.22273754
https://doi.org/10.1101/2022.04.11.22273754
Autor:
Iris Martínez Juárez, Laura Hernández Vanegas, Reyna María Durón, Michele Breda Yepes, Andrea Santos Peyret
Publikováno v:
Innovare: Revista de ciencia y tecnología. 8:38-45
La epilepsia constituye un problema de salud a nivel mundial y en países en desarrollo. En México se estima que hay uno a dos millones de personas con esta condición. El Programa Prioritario de Epilepsia en México cuenta con varios Centros de Ate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07177a938d42f502f93d8c3d6a3cc276
https://doi.org/10.5377/innovare.v8i1.8106
https://doi.org/10.5377/innovare.v8i1.8106